
Risklick develops Protocol AI TM, an end-to-end AI-driven software solution that enables experts to rapidly design and develop high-quality clinical trial protocols and study plans. The platform leverages a comprehensive database of over 800,000 clinical trials linked to publications, regulatory approvals, and safety data to optimize study design and accelerate clinical development timelines. It integrates with electronic trial systems like EDC and eTMF to streamline protocol implementation and change management, reducing protocol development time by 50%, amendments by 20%, and implementation time by 40%. Risklick's business model is subscription-based, targeting pharmaceutical companies and clinical research organizations to improve precision and efficiency in clinical trial protocol development, thereby accelerating market access for new treatments.

Risklick develops Protocol AI TM, an end-to-end AI-driven software solution that enables experts to rapidly design and develop high-quality clinical trial protocols and study plans. The platform leverages a comprehensive database of over 800,000 clinical trials linked to publications, regulatory approvals, and safety data to optimize study design and accelerate clinical development timelines. It integrates with electronic trial systems like EDC and eTMF to streamline protocol implementation and change management, reducing protocol development time by 50%, amendments by 20%, and implementation time by 40%. Risklick's business model is subscription-based, targeting pharmaceutical companies and clinical research organizations to improve precision and efficiency in clinical trial protocol development, thereby accelerating market access for new treatments.
Headquarters: Bern, Switzerland
Flagship product: Protocol AI — AI-driven clinical trial protocol design platform
Database size: Over 800,000 clinical trials
Founded: 2019
Funding: Seed round led by Debiopharm Innovation Fund (Apr 23, 2024)
Clinical trial protocol design and study planning for pharmaceutical and medical device companies
2019
Biotechnology Research
“Debiopharm Innovation Fund is a lead/sole investor in disclosed Seed round”
| Company |
|---|
About Risklick
Risklick is a leading AI software company based in Bern, specializing in advanced solutions for clinical trial protocol development.
Our flagship product, Protocol AI, leverages artificial intelligence to empower clinical experts to design evidence-based clinical trial protocols, optimize study design, and generate high-quality protocols in a fraction of the time. We are transforming how clinical trial protocols are designed, written, and managed—enabling biopharma companies to develop truly digital, data-driven protocols for the future.
We are now seeking a passionate and highly skilled Senior Clinical Scientist to join our team. In this role, you will play a key part in shaping and enhancing our AI-powered Protocol AI platform, helping us redefine protocol development and advance the next generation of clinical trial design.
Contribute to the scientific roadmap for Protocol AI and ensure all outputs reflect current scientific and clinical best practices
Develop and enhance scientific methodologies, structured authoring principles, and clinical trial design logic within the platform
Monitor scientific, biomedical, and regulatory developments to keep Protocol AI scientifically robust and aligned with industry standards
Collaborate with Product, Engineering, and AI teams to ensure scientific accuracy, clinical relevance, and high-quality feature development
Serve as the primary scientific/medical escalation point for internal teams and external stakeholders
Support onboarding, pilots, and enterprise implementations with strong scientific guidance
Represent Risklick in conferences, panels, workshops, and scientific working groups
contribute to scientific publications, white papers, case studies, and educational content promoting structured and digital-first protocol development
Required Qualifications
Degree in scientific/life-sciences field. PharmD, or MD preferred
Minimum of 6 years of experience in clinical development with at least 4 years of clinical trial design and protocol development within pharma, biotech, or CRO organizations
Ability to work independently, multi-task, and work in a fast-paced environment
Strong analytical and problem-solving ability; able to evaluate scientific inputs, identify gaps, and propose evidence-driven improvements
Comfortable to use AI-enabled tools and technologies within scientific and clinical contexts
Bonus Skills
Experience implementing study designs and clinical protocols using digital solutions
Understanding of data models and clinical standards (CDISC, SNOMED, MeSH, MeDRA, ontologies)
What We Offer
A potential strategic leadership role in a fast-growing Swiss company
Opportunity to contribute to the future of an end-to-end digital study design and protocol development ecosystem.